Zhu Bo-Yu, Liu Zhi-Chao, Zhao Zhen-Xi, Huang Hui-Ping, Zhang Na, Xia Jia, Chen Wei-Wei
Department of Rheumatology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.
Chin J Integr Med. 2025 Feb;31(2):157-169. doi: 10.1007/s11655-024-3762-0. Epub 2024 Sep 5.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder affecting multiple systems, characterized by the development of harmful autoantibodies and immune complexes that lead to damage in organs and tissues. Chinese medicine (CM) plays a role in mitigating complications, enhancing treatment effectiveness, and reducing toxicity of concurrent medications, and ensuring a safe pregnancy. However, CM mainly solves the disease comprehensively through multi-target and multi-channel regulation process, therefore, its treatment mechanism is often complicated, involving many molecular links. This review introduces the research progress of pathogenesis of SLE from the aspects of genetics, epigenetics, innate immunity and acquired immunity, and then discusses the molecular mechanism and target of single Chinese herbal medicine and prescription that are commonly used and effective in clinic to treat SLE.
系统性红斑狼疮(SLE)是一种影响多个系统的慢性自身免疫性疾病,其特征是产生有害的自身抗体和免疫复合物,导致器官和组织受损。中医在减轻并发症、提高治疗效果、降低同时使用药物的毒性以及确保安全妊娠方面发挥着作用。然而,中医主要通过多靶点、多途径的调节过程来全面解决疾病问题,因此其治疗机制往往较为复杂,涉及许多分子环节。本文综述从遗传学、表观遗传学、固有免疫和获得性免疫等方面介绍SLE发病机制的研究进展,然后探讨临床常用且有效的单味中药及方剂治疗SLE的分子机制和靶点。